Signaling Pathways - angiogenesis - MET - c-Kit - adrenergic receptor
清除全部
-
B5954 Dasatinib Monohydrate中文名: 达沙替尼一水合物Target: PDGFR|c-Kit|Bcr-Abl|SrcSummary: ABL\SRC\KIT\PDGFR以及其它酪氨酸激酶抑制剂 -
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI) -
B5854 Pexidartinib (PLX3397)3 Citation中文名: 培西达替尼Target: FLT3|c-Kit|CSF1RSummary: CSF-1R抑制剂 -
B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂 -
B1358 Epinephrine Bitartrate中文名: 酒石酸肾上腺素Target: adrenergic receptorSummary: 肾上腺素能受体激动剂 -
B1572 LatrepirdineTarget: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptorSummary: 脑细胞死亡抑制剂 -
B1438 BMS-794833Target: MET|Flk-1Summary: Met/VEGFR2抑制剂 -
B2171 Imatinib (STI571)中文名: 伊马替尼Target: PDGFR|c-Kit|Bcr-AblSummary: 蛋白酪氨酸激酶抑制剂 -
A8550 Telatinib (BAY 57-9352)中文名: 替拉替尼Target: VEGFR|PDGFR|c-KitSummary: VEGFR-2/-3、PDGFR-β和c-Kit抑制剂 -
A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met（野生型/突变型）抑制剂